Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ximena Camacho

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Oncology|July 13, 2025
Preclinical Evaluation of 99mTc-Labeled LHRH Analog as Cancer Receptor ImagingLucía Alfaya, Ximena Camacho, Mirel Cabrera, et al.
Cancer|January 10, 2018
Chinese and South Asian ethnicity, immigration status, and clinical cancer outcomes in the Ontario Cancer SystemJames K R Stevenson, Matthew C Cheung, Craig C Earle, et al.
Anti-Cancer Agents in Medicinal Chemistry|March 9, 2017
Tocilizumab Labeling with 99mTechnetium via HYNIC as a Molecular Diagnostic Agent for Multiple MyelomaXimena Camacho, Camila Longo Machado, Maria Fernanda García, et al.
Health & Place|July 13, 2024
Health map for HealthGap: Defining a geographical catchment to examine cardiovascular risk in Victoria, AustraliaKaren E Lamb, Ximena Camacho, Ping-Wen Lee, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 12, 2024
Enhanced Tumor Targeting of Radiolabeled Mouse/Human Chimeric Anti-Tn Antibody in Losartan-Treated Mice Bearing Tn-Expressing Lung TumorsMarcos Tassano, Ximena Camacho, Teresa Freire, et al.
International Journal of Population Data Science|July 5, 2022
The Medicines Intelligence Centre of Research Excellence: Co-creating real-world evidence to support the evidentiary needs of Australian medicines regulators and payersNicole Pratt, Ximena Camacho, Claire Vajdic, et al.
Oncology|January 19, 2013
[(99m)Tc(CO)(3)]-radiolabeled bevacizumab: in vitro and in vivo evaluation in a melanoma modelXimena Camacho, María Fernanda García, Victoria Calzada, et al.
Frontiers in Surgery|March 6, 2020
The Surgeon's Role in the Opioid Crisis: A Narrative Review and Call to ActionCade Shadbolt, J Haxby Abbott, Ximena Camacho, et al.
Anti-Cancer Agents in Medicinal Chemistry|August 12, 2024
Molecular Imaging of Melanoma VEGF-expressing Tumors through [<sup>99m</sup>Tc]Tc-HYNIC-Fab(Bevacizumab)Ximena Camacho, Carolina Perroni, Lucía Alfaya, et al.
Pharmacoepidemiology and Drug Safety|March 13, 2024
Medicine utilization studies in Australian individual-level dispensing data: A blinded, multi-center replicated analysisMalcolm B Gillies, Chrianna Bharat, Ximena Camacho, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Oncology|July 13, 2025
Preclinical Evaluation of 99mTc-Labeled LHRH Analog as Cancer Receptor ImagingLucía Alfaya, Ximena Camacho, Mirel Cabrera, et al.
Cancer|January 10, 2018
Chinese and South Asian ethnicity, immigration status, and clinical cancer outcomes in the Ontario Cancer SystemJames K R Stevenson, Matthew C Cheung, Craig C Earle, et al.
Anti-Cancer Agents in Medicinal Chemistry|March 9, 2017
Tocilizumab Labeling with 99mTechnetium via HYNIC as a Molecular Diagnostic Agent for Multiple MyelomaXimena Camacho, Camila Longo Machado, Maria Fernanda García, et al.
Health & Place|July 13, 2024
Health map for HealthGap: Defining a geographical catchment to examine cardiovascular risk in Victoria, AustraliaKaren E Lamb, Ximena Camacho, Ping-Wen Lee, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 12, 2024
Enhanced Tumor Targeting of Radiolabeled Mouse/Human Chimeric Anti-Tn Antibody in Losartan-Treated Mice Bearing Tn-Expressing Lung TumorsMarcos Tassano, Ximena Camacho, Teresa Freire, et al.
International Journal of Population Data Science|July 5, 2022
The Medicines Intelligence Centre of Research Excellence: Co-creating real-world evidence to support the evidentiary needs of Australian medicines regulators and payersNicole Pratt, Ximena Camacho, Claire Vajdic, et al.
Oncology|January 19, 2013
[(99m)Tc(CO)(3)]-radiolabeled bevacizumab: in vitro and in vivo evaluation in a melanoma modelXimena Camacho, María Fernanda García, Victoria Calzada, et al.
Frontiers in Surgery|March 6, 2020
The Surgeon's Role in the Opioid Crisis: A Narrative Review and Call to ActionCade Shadbolt, J Haxby Abbott, Ximena Camacho, et al.
Anti-Cancer Agents in Medicinal Chemistry|August 12, 2024
Molecular Imaging of Melanoma VEGF-expressing Tumors through [<sup>99m</sup>Tc]Tc-HYNIC-Fab(Bevacizumab)Ximena Camacho, Carolina Perroni, Lucía Alfaya, et al.
Pharmacoepidemiology and Drug Safety|March 13, 2024
Medicine utilization studies in Australian individual-level dispensing data: A blinded, multi-center replicated analysisMalcolm B Gillies, Chrianna Bharat, Ximena Camacho, et al.
Pageof 6